Who invested in Azeria Therapeutics?
Azeria Therapeutics's investors include Syncona.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$41Mraised across 1 round since 2019, from 1 source
Azeria Therapeutics's investors include Syncona.
Azeria Therapeutics has raised $41M across 1 round since 2019.
Azeria Therapeutics's most recent round was a Series B of $41M in Nov 2019.
Its most recent round, $41M in Nov 2019, is also its largest on record.
Azeria Therapeutics's first round on record, in Nov 2019, was backed by Syncona.
Azeria Therapeutics's latest named round is a Series B, in Nov 2019.
Azeria Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.